NEUROMYELITIS OPTICA

Clinical trials for NEUROMYELITIS OPTICA explained in plain language.

Never miss a new study

Get alerted when new NEUROMYELITIS OPTICA trials appear

Sign up with your email to follow new studies for NEUROMYELITIS OPTICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 5 Completed 2 Terminated 1

Experimental pill for rare nerve disease shows early promise in tiny trial

Disease control Terminated

This early-phase trial tested the drug zanubrutinib in just 6 adults with neuromyelitis optica spectrum disorder (NMOSD), a rare condition where the immune system attacks the nerves. Participants took the pill twice daily for a year to see if it could prevent relapses. However, t…

Matched conditions: NEUROMYELITIS OPTICA

Phase: PHASE2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC

NEUROMYELITIS OPTICA

Get alerted when new NEUROMYELITIS OPTICA trials appear

Experimental pill for rare nerve disease shows early promise in tiny trial